Skip to main content

Table 6 Frequency of antibiotic resistance profiles among different clusters

From: Characterization of genotypes and antimicrobial resistance profiles of clinical isolates of Shigella from patients in the southern region of Iran

Clusters

A1

A2

A3

A4

A5

A6-1

A6-2

A8

A9

A10

A11

Antibiotics

Ampicillin

2 (100)

3 (100)

5 (100)

2 (100)

4 (80)

8 (100)

6 (100)

9 (90)

2 (100)

3 (100)

7 (100)

Azithromycin

0 (0.0)

0 (0.0)

0 (0.0)

1 (50)

1 (20)

3 (37.5)

1 (16.7)

6 (60)

0 (0.0)

1 (33.3)

0 (0.0)

Ceftriaxone

2 (100)

2 (66.6)

5 (100)

2 (100)

3 (60)

8 (100)

5 (83.3)

9 (90)

2 (100)

1 (33.3)

3 (42.9)

Cefotaxime

2 (100)

2 (66.6)

5 (100)

2 (100)

3 (60)

8 (100)

5 (83.3)

9 (90)

2 (100)

2 (66.6)

3 (42.9)

Ceftazidime

1 (50)

2 (66.6)

1 (20)

1 (50)

2 (40)

6 (75)

3 (50)

0 (0.0)

2 (100)

0 (0.0)

2 (28.6)

Ceftizoxime

1 (50)

2 (66.6)

4 (80)

1 (50)

2 (40)

7 (87.5)

6 (100)

2 (20)

2 (100)

1 (33.3)

3 (42.9)

Cefixime

2 (100)

3 (100)

5 (100)

2 (100)

4 (80)

8 (100)

5 (83.3)

9 (90)

2 (100)

1 (33.3)

3 (42.9)

Cefoxitin

1 (50)

1 (33.3)

0 (0.0)

0 (0.0)

2 (40)

0 (0.0)

0 (0.0)

1 (10)

0 (0.0)

0 (0.0)

0 (0.0)

Chloramphenicol

0 (0.0)

0 (0.0)

0 (0.0)

1 (50)

0 (0.0)

3 (37.5)

2 (33.3)

0 (0.0)

0 (0.0)

1 (33.3)

1 (14.3)

Ciprofloxacin

2 (100)

3 (100)

4 (80)

0 (0.0)

4 (80)

3 (37.5)

2 (33.3)

3 (30)

1 (50)

1 (33.3)

6 (85.7)

Nalidixic acid

1 (50)

1 (33.3)

1 (20)

0 (0.0)

3 (60)

1 (12.5)

0 (0.0)

8 (80)

0 (0.0)

1 (33.3)

1 (14.3)

Norfloxacin

1 (50)

0 (0.0)

1 (20)

0 (0.0)

2 (40)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Ofloxacin

0 (0.0)

0 (0.0)

1 (20)

0 (0.0)

2 (40)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Piperacillin–tazobactam

2 (100)

3 (100)

5 (100)

2 (100)

4 (80)

8 (100)

5 (83.3)

9 (90)

1 (50)

3 (100)

5 (71.4)

Trimethoprim–sulfamethoxazole

2 (100)

3 (100)

3 (60)

2 (100)

3 (60)

7 (87.5)

3 (50)

10 (100)

2 (100)

2 (66.6)

7 (100)

Total

2 (100)

3 (100)

5 (100)

2 (100)

5 (100)

8 (100)

6 (100)

10 (100)

2 (100)

3 (100)

7 (100)